Modulation of the discriminative stimulus properties of (−)-nicotine by diazepam and ethanol
✍ Scribed by David J. B. Kim; Jorge D. Brioni
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 669 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The effect of different ligands for the GABA‐BZD receptor and the NMDA receptor were studied in rats trained to discriminate (−)‐nicotine (1.9 μmol/kg) from saline in a standard two‐bar operant conditioning paradigm with food reinforcement. MK‐801 (0.03–0.3 μmol/kg), flumazenil (10–30 μmol/kg), and Ro 15–4513 (3–10 μmol/kg) did not generalize to (−)‐nicotine on nicotine‐trained rats, and when tested as antagonists they did not block the nicotine cue. Diazepam (3–10 μmol/kg) and ethanol (11–22 mmol/kg) did not have any effect by themselves, but they significantly attenuated the nicotine cue by 53 and 65%, respectively, without affecting the response rates of the animals. Pre‐treatment with flumazenil (30 μmol/kg) reversed the effect of diazepam but it did not reverse the effect of ethanol on the discriminative stimulus properties of (−)‐nicotine. The effect of ethanol was not blocked by Ro 15–4513 (10 μmol/kg). These data indicate that diazepam and ethanol modulate the expression of the nicotine cue and that the effect of diazepam is mediated via a benzodiazepine receptor mechanism. © Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The prototypic nicotinic acetylcholinergic receptor (nAChR) agonist, nicotine, is one of the primary psychoactive ingredients of tobacco. This review examines the effects of nicotine and similar compounds in nicotine discrimination procedures, a paradigm in which the subjective effects of nicotine c
The novel anxiolytic ipsapirone appears to interact selectively with 5-hydroxytryptaminelA (5-HT1\*) receptors. The present study investigated 1) the discriminability of ipsapirone using a two-lever, water-reinforced task and 2) the importance of 5-HTIA and catecholamine systems in the ipsapirone cu